18.12.2017 15:59:00
|
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galectin Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, Dec. 18, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Galectin Therapeutics Inc. (NASDAQ: GALT).
If you are a shareholder of Galectin Therapeutics Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:
http://pjlfirm.com/galectin-therapeutics-inc/
You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.
Purcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http://pjlfirm.com. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Purcell Julie & Lefkowitz LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Galectin Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Galectin Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Galectin Therapeutics Inc | 1,18 | 5,36% |